MEDICAL MARIJUANA, INC. News
More:  CANNABIS NEWS      SHOP     CONTACT
  • About Us
    • Company
    • We are a company of firsts
    • Marijuana Industry Overview
    • careers
  • Shop
    • CBD Products
    • Mood
    • Sleep
    • Beauty
  • News
    • Press Releases
    • Media Coverage
  • CBD Oil 101
    • CBD il: The Basics
    • Shop CBD Oil
    • CBD OIL FAQ´S
    • Is CBD Psychoactive?
    • CBD Serving: What is the Proper Serving Size?
    • CBD Vs THC – What Is The Difference?
    • VAPING 101
    • CBD Oil Recipes
  • Cannabis 101
    • What’s the Difference Between Hemp vs. Marijuana?
    • Where is Medical Marijuana Legal?
    • CBD Vs THC – What Is The Difference?
    • Marijuana Side Effects
    • How Long Does THC Stay in Your System?
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
Medical Marijuana, Inc. Family of Companies Surpass Last Year’s Revenue with 5 Months Left in 2018

Medical Marijuana, Inc. Family of Companies Surpass Last Year’s Revenue with 5 Months Left in 2018

by adminTorusBrand | Aug 3, 2018 | Axim Biotechnologies, Company News, HempMeds, Kannalife, Kannalife Sciences, Kannaway

Medical Marijuana, Inc. rides momentum from first half of the year to pass last year’s revenue numbers with just five months left in 2018 Medical Marijuana, Inc. started off the year on the right foot in January – hitting record revenue numbers for the month. It is a...
CNBC, Verdict, Seeking Alpha, and More Feature News from Medical Marijuana, Inc.

CNBC, Verdict, Seeking Alpha, and More Feature News from Medical Marijuana, Inc.

by adminTorusBrand | Jul 27, 2018 | Kannalife, Kannalife Sciences, Kannaway, Media Coverage

Medical cannabis for NFL players, decriminalization of CBD in Mexico, and CBD for Pets lead our headlines this week. The Medical Marijuana, Inc. family of companies once again dominated the cannabis news cycle this week as our companies, brands, and spokespersons were...
Kannalife Sciences Spokesman Nick Lowery Talks About Efforts to Develop CTE Treatment with Reiter Than You

Kannalife Sciences Spokesman Nick Lowery Talks About Efforts to Develop CTE Treatment with Reiter Than You

by adminTorusBrand | Nov 21, 2017 | Kannalife, Media Coverage, Uncategorized

The former NFL player and current Kannalife™ Sciences spokesman talked about the efforts to develop a cannabinoid-based treatment for CTE, a disease plaguing players in the NFL. Kannalife™ Sciences spokesperson Nick Lowery was recently invited to the Reiter Than You...
Listen: KC’s Between the Lines Radio Welcomes Home Kannalife Sciences Spokesman Nick Lowery to Discuss Benefits of CBD for CTE

Listen: KC’s Between the Lines Radio Welcomes Home Kannalife Sciences Spokesman Nick Lowery to Discuss Benefits of CBD for CTE

by adminTorusBrand | Nov 1, 2017 | Kannalife, Media Coverage

Former National Football League (NFL) player and current KannalifeTM Sciences spokesperson Nick Lowery recently visited with Kansas City’s Between the Lines radio show to discuss the current state of the NFL and how hemp-derived cannabidiol (CBD) treatments may play a...

Recent Posts

  • Medical Marijuana, Inc. Kannaway Division Completes Acquisition of KZ1 Network Marketing Company
  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets

Recent Comments

No comments to show.

SUBSCRIBE AND GET THE LATES NEWS

* indicates required

Follow us on

social networks

  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

Home     Company     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.